Limonene (1-methyl-4-(1-methylethenyl)-cyclohexene) — Hermetica Encyclopedia
Named Bioactive Compounds · Compound

Limonene (1-methyl-4-(1-methylethenyl)-cyclohexene)

Moderate Evidencecompound4 PubMed Studies

Hermetica Superfood Encyclopedia

The Short Answer

Limonene is a monocyclic monoterpene found abundantly in citrus peel oils, comprising up to 97% of orange peel essential oil. It interacts with adenosine receptors and cytochrome P450 enzymes, and is primarily studied for antioxidant and potential chemopreventive properties in preclinical models.

4
PubMed Studies
0
Validated Benefits
Synergy Pairings
At a Glance
CategoryNamed Bioactive Compounds
GroupCompound
Evidence LevelModerate
Primary Keywordlimonene supplement benefits
Synergy Pairings5
Limonene close-up macro showing natural texture and detail — rich in anti-inflammatory, antioxidant, anxiolytic
Limonene (1-methyl-4-(1-methylethenyl)-cyclohexene) — botanical close-up

Health Benefits

Origin & History

Limonene growing in natural environment — natural habitat
Natural habitat

Limonene is a cyclic monoterpene hydrocarbon (C₁₀H₁₆) primarily extracted from citrus fruit peels and rinds, particularly oranges and lemons, though it also occurs in pine needles and mint. Commercial production involves steam distillation of citrus peels, centrifugal separation from citrus oils, or fractional distillation, with the (R)-(+)-d-limonene enantiomer being the predominant form in citrus sources.

The research dossier contains no information on historical or traditional medicinal uses of limonene in any medical systems or cultural contexts.Traditional Medicine

Scientific Research

The research dossier explicitly states that no human clinical trials, randomized controlled trials (RCTs), or meta-analyses for limonene were found in the search results. No PubMed PMIDs, study designs, sample sizes, or clinical outcomes are available in the provided sources.

Preparation & Dosage

Limonene traditionally prepared — pairs with No synergistic compounds identified in clinical research
Traditional preparation

No clinically studied dosage ranges, forms, or standardization details are available in the current research. Consult a healthcare provider before starting any new supplement.

Nutritional Profile

{"macronutrients": {"protein": "Not applicable", "fiber": "Not applicable", "carbohydrates": "Not applicable", "fats": "Not applicable"}, "micronutrients": {"vitamins": "Not applicable", "minerals": "Not applicable"}, "bioactive_compounds": {"limonene": "100% of compound", "concentration": "Pure compound, no additional bioactive compounds present"}, "bioavailability_notes": "Limonene is lipophilic and has low water solubility (14 mg/L), which may affect its absorption and distribution in biological systems."}

How It Works

Mechanism of Action

Limonene is metabolized hepatically via cytochrome P450 enzymes (CYP2C9, CYP3A4) into active metabolites including perillic acid, dihydroperillic acid, and uroterpenol. These metabolites have been shown in preclinical studies to inhibit Ras protein isoprenylation and modulate the mevalonate pathway, potentially disrupting tumor cell proliferation signaling. Limonene and its metabolites also exhibit free radical scavenging activity and may upregulate phase II detoxification enzymes such as glutathione S-transferase.

Clinical Evidence

Human clinical evidence for limonene is extremely limited, with no large-scale randomized controlled trials confirming therapeutic benefits. A small Phase I clinical trial (n=32) by Vigushin et al. (1998) evaluated oral d-limonene in cancer patients at doses up to 8g/day and identified perillic acid as the primary plasma metabolite, but did not demonstrate significant tumor response. A separate pilot study in breast cancer patients suggested modest biological activity at high oral doses, though results were not statistically robust. Overall, the existing human data is insufficient to support health claims, and most mechanistic understanding derives from in vitro and rodent studies.

Safety & Interactions

Limonene is generally recognized as safe (GRAS) by the FDA as a food flavoring agent at typical dietary exposure levels, but high supplemental doses (above 1–2g/day) may cause gastrointestinal upset including reflux, nausea, and heartburn. Because limonene is metabolized by CYP3A4 and CYP2C9, it carries a theoretical risk of interacting with drugs that share these pathways, such as statins, benzodiazepines, and warfarin, potentially altering their plasma concentrations. Topical exposure can cause contact dermatitis and skin sensitization, particularly with oxidized limonene. Safety during pregnancy and breastfeeding has not been established in human studies, and supplemental use should be avoided in these populations.

Synergy Stack

Hermetica Formulation Heuristic

Also Known As

D-limoneneL-limonenedipentene4-isopropenyl-1-methylcyclohexenecitrus terpeneorange oil terpenep-mentha-1,8-diene1-methyl-4-isopropenylcyclohexenelimonene hydrocarbon

Frequently Asked Questions

What does limonene do in the body?
After oral ingestion, limonene is rapidly absorbed and metabolized by hepatic CYP450 enzymes into metabolites such as perillic acid and uroterpenol, which circulate in plasma. These metabolites may inhibit the mevalonate pathway and Ras protein function in preclinical models, but equivalent effects have not been confirmed in human clinical trials.
Is limonene safe to take as a supplement?
Limonene is FDA-designated GRAS as a food flavoring, but supplemental doses exceeding 1–2g/day have been associated with acid reflux, nausea, and gastrointestinal irritation in Phase I clinical observations. Individuals taking CYP3A4-metabolized medications such as atorvastatin or midazolam should consult a physician before supplementing, due to potential enzyme competition.
What foods are high in limonene?
Limonene is most concentrated in the peel and rind of citrus fruits, with cold-pressed orange peel oil containing up to 97% limonene by composition. It is also present in smaller amounts in caraway seeds, dill, fennel, and celery seeds. Dietary intake through whole foods is far lower than the gram-level doses used in clinical trials.
Does limonene have anti-cancer properties?
Preclinical studies in rodent models have shown that d-limonene and its metabolite perillic acid can inhibit mammary, liver, and lung tumor growth by disrupting Ras isoprenylation and inducing apoptosis. A Phase I human trial by Vigushin et al. tested oral limonene at up to 8g/day in cancer patients and detected active metabolites in plasma, but did not demonstrate objective tumor responses. No Phase II or III trials have confirmed anticancer efficacy in humans.
What is the difference between d-limonene and l-limonene?
D-limonene and l-limonene are enantiomers — mirror-image molecules with the same chemical formula (C10H16) but different spatial configurations. D-limonene, derived predominantly from orange peel, has the characteristic citrus scent and is the form used in most supplement and clinical research. L-limonene is found in spearmint and pine oils and has a distinct piney odor; it has been studied far less for biological activity.
Does limonene have bioavailability issues due to its low water solubility?
Yes, limonene's low water solubility (14 mg/L) and lipophilic nature present significant bioavailability challenges when formulated as a supplement. This means limonene is better absorbed when consumed with dietary fats or formulated in specialized delivery systems like liposomal or nanoemulsion forms. Water-based supplement formulations may have reduced absorption compared to consumption from whole food sources where limonene is naturally present in an optimal lipid matrix.
Are there any known drug interactions between limonene supplements and common medications?
Limited human data exists on limonene's potential drug interactions due to the absence of clinical trials in humans. However, because limonene is lipophilic and may interact with hepatic metabolism pathways, individuals taking medications metabolized by cytochrome P450 enzymes should consult a healthcare provider before supplementing. Current evidence does not establish specific contraindications, but caution is warranted given the lack of human safety studies.
Why does limonene research quality vary so much between test-tube studies and human evidence?
Most limonene research consists of in vitro and animal studies that cannot be reliably translated to human health outcomes, which is why no clinical benefits can be claimed for supplementation. Human studies are lacking entirely, meaning promising laboratory results do not have corresponding human clinical trial data to support therapeutic claims. This gap between basic research and clinical evidence is a critical limitation when evaluating limonene's actual health effects in people.

Explore the Full Encyclopedia

7,400+ ingredients researched, verified, and formulated for optimal synergy.

Browse Ingredients
These statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.